Board of Directors



Daniel R. Frank

Mr. Frank started his investment career in 1979 as an analyst with Fidelity Management and Research "Fidelity Investments". In 1981, he became an assistant to Peter Lynch on Fidelity Magellan Fund, and in 1982, he formally launched his own fund "Fidelity Special Situations/Strategic Opportunities Fund" which grew to over $800 million. For the past decade Mr. Frank was a Managing Director at Cerberus Capital Management responsible for healthcare related investments, in both the public and private markets, from start-ups to established businesses in need of growth capital. In this role, he served as lead investor, co-investor, and various roles on the Board of Directors of the respective investments. The areas of focus encompassed diagnostics, specialty pharmaceuticals and medical devices.

Robert T. Leonard

Mr. Leonard is Glytec's CEO and also serves on the Board of Directors. Mr. Leonard has over 25 years' experience in healthcare in various general management, senior sales and marketing positions. His experience encompasses information technology, hospital information systems, point-of-care devices, disease management and alternate site services; all relevant to the composition of Glytec's unique offering. Previous employers include, PatientKeeper, provider of physician healthcare information systems, which grew from zero to 450 hospital clients during his tenure; McKesson Information Systems, FluidSense (IV /fluid management) and Chartwell, a series of academic medical center partnerships focused on alternate site care. Mr. Leonard has a proven track record of developing and leading high quality, high performance teams in fast growth companies. In his present role, as in several previous, he is responsible for developing and implementing the strategic vision of the company and more importantly, ensuring the company's culture is driven by an unwavering focus on the success and improved health of the hospitals and patients it was created to serve.

Patrick Cua

Mr. Cua's bio will be available soon.

Jay Fleischman, MD

Dr. Fleischman is Clinical Associate Professor of Ophthalmology at Albert Einstein College of Medicine. He was a systems analyst/programmer at New York’s NASA Goddard Institute for Space Studies while he completed his applied math/computer engineering and then medical degrees at Columbia University. He completed his ophthalmology training at the Wilmer Institute, Johns Hopkins and his retina specialty training at the Medical College of Wisconsin. In 1980, Dr. Fleischman became the Director of Retina at the Bethesda Eye Institute, St. Louis University and then served as Director at Montefiore Hospital, Albert Einstein College of Medicine to New York in 1988. Since 1984, Dr. Fleischman has lectured and taught surgery around the world through Project ORBIS (the Flying Eye Hospital), has authored many papers, and holds patents, one pending on a device that will help restore vision to patients with macular degeneration, the leading cause of vision loss after age 55. Of the many surgical devices Dr. Fleischman has invented, the laser endophotocoagulator has become an indispensable tool and a worldwide “standard of care” for advanced surgical retina cases. An expert in diabetes treatment and its complications, in particular diabetic retinopathy, he served as an investigator in The Diabetes Control and Complications Trial (DCCT), a landmark medical study conducted by the US National Institute of Diabetes and Digestive and Kidney Diseases. Dr. Fleischman has consulted for many companies including HGM, Alcon and Mentor and served as an advisor for Dauphin Capital Management and NGN Capital Management. As a Pfizer medical advisor at their Hospital Products Division he helped them evaluate many innovative medical devices and surgical instruments which served to increase the 1998 sale value of that division. He now serves as an FDA medical device panel member.

C. Edward Floyd, MD

Dr. Floyd is the founder and president of Floyd Medical Associates in Florence, South Carolina. He is a graduate of the University of South Carolina and completed his internship and residence at Charity Hospital in New Orleans, Louisiana. Dr. Floyd is a Clinical Professor of Surgery, USC Medical School, Columbia, South Carolina, and a Clinical Professor of Surgery, MUSC Medical School, Charleston, South Carolina.

Paul Fulchino

Mr. Fulchino's experience spans 40 years as a business executive and strategic advisor to senior management. He has demonstrated a consistent record of achievement in his roles as Chairman, President and Chief Executive Officer of Aviall, Inc. (1999-2010), the world's largest aircraft parts service provider; President and Chief Operating Officer of B/E Aerospace (1996-1999), the largest aircraft interiors manufacturer; and as President and Vice Chairman of Mercer Management Consulting (now Oliver Wyman Associates) (1976-1996), one of the leading international consulting firms. In each of these entities, Mr Fulchino led the organizations to double digit annual growth in revenues and profitability. In addition to his public and private Company leadership roles, Mr. Fulchino serves on several Boards including Spirit Aerosystems, Wesco, Global Technology Systems and non-profit Boards such as the Boston College Athletic Advisory Council. His notable prior Board roles include The Sports Authority, Medsource Technologies and Mercer Consulting. Mr. Fulchino attended the United States Military Academy, received an A.B. in mathematics from Boston College, and earned his M.B.A. from Columbia University Graduate School of Business with a concentration in finance and operations research.

Andrew Midler

Mr. Midler serves as Managing Member at Savitr Capital, LLC which has its primary focus in health care venture investments. Mr. Midler founded the firm in 2008. Previously, Mr. Midler served as the Chief Executive Officer and Chief Investment Officer at Standard Pacific Capital. From 1986 to 1993, he worked as a Portfolio Manager at Fidelity Investments. Mr. Midler holds an M.B.A. from Harvard Business School. He earned M.A. and B.A. degrees in Political Science from Stanford University.

Cheryl Pegus, MD, MPH

Dr. Pegus is the President of the American Heart Association (AHA) Founder's 2013. Previously she was the Chief Medical Officer for Walgreens. Dr. Pegus is a Director of Vision-Sciences, Inc. (Nasdaq:VCSI), Caluent and Glytec. She has served as the General Manager and Chief Medical Officer for Symcare, a J&J company that provides innovative care management solutions utilizing remote monitoring. Prior to Symcare, Dr. Pegus was the head of clinical products for Aetna's Medical Products business unit. She is a member of the Dean's Circle at Weill Cornell Medical College and a strategic advisor to HealthFleet, Inc.

Lynn Vogel, PhD

Dr. Vogel was Vice President and Chief Information Officer at The University of Texas MD Anderson Cancer Center (UT-MDACC) in Houston, Texas. Previous CIO and IT VP leadership positions were at The University of Chicago Hospitals, and at Mount Sinai Medical Center and New York Presbyterian Healthcare in New York City. He has also served as a faculty member in Biomedical Informatics (Columbia University-New York City) and Bioinformatics/Computational Biology (UT-MDACC). For several years, Dr. Vogel served on the National Cancer Institute's National Cancer Advisory Board Informatics Working Group. He is a Member and Fellow (FHIMSS) of the Healthcare Information Management Systems Society (HIMSS), and a Fellow (FCHIME) and Life Fellow (LCHIME) of the College of Healthcare Information Management Executives (CHIME), where he was a Charter Member, and previously served as Board Member and Board Chair and was a faculty member of the CHIME CIO Boot Camp. Most recently, he has worked with Encore Health Resources, has been a Senior Advisor to Sophic Alliance, and to Next Wave Health/Next Wave Connect, and currently works with Next Wave Health Advisors. Dr. Vogel's education at the bachelor's, masters and doctoral level was completed at The University of Chicago.